AMAT
Applied Materials, Inc.
AMAT has the edge over CRWD overall, supported by stronger valuation.
CRWD
CrowdStrike Holdings, Inc.
CRWD has lower modeled downside risk, despite its lower overall score.
AMAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMAT's revenue, profitability, cash flow and balance sheet are all currently strong.
CRWD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Unavailable |
CRWD's revenue and cash flow are currently healthy, and its profitability is stable. There isn't enough data to rate its balance sheet.
AMAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $205 | -46% |
| Forward | 20x | $381 | — |
| Fair | 21x | $263 | -31% |
| Expensive | 29x | $365 | -4.1% |
| Current | 30x | $381 | — |
Historical ranges are pointers, not guarantees.
AMAT has the edge over CRWD in the historical PE scenario, which offers more potential upside but is not a forecast.
CRWD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 153x | $230 | — |
| Cheap | 451x | $27.04 | -88% |
| Fair | 715x | $42.92 | -81% |
| Expensive | 3,337x | $200 | -13% |
| Current | 3,678x | $230 | — |
Historical ranges are pointers, not guarantees.
CRWD's PE is in its expensive range at 3678x. If earnings grow as analysts expect, today's price would be 153x next year's earnings, in its cheap range.
AMAT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for AMAT, with profitability improving.
CRWD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Broad | |
| High |
Analysts expect strong earnings and revenue growth for CRWD, with profitability improving.
AMAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $18.83 | +49% |
| Q4 2026 | $12.62 | +46% |
AMAT has the edge over CRWD in the latest year-over-year earnings comparison.
CRWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.50 | +2400% |
| Q3 2026 | $0.06 | +$0.36 |
| Q2 2026 | -$0.03 | +$0.14 |
| Q1 2026 | -$0.16 | -$0.14 |
| Q4 2025 | -$0.32 | -346% |
| Q3 2025 | -$0.30 | -276% |
| Q2 2025 | -$0.17 | -221% |
| Q1 2025 | -$0.02 | -122% |
| Q4 2024 | $0.13 | +$0.15 |
CRWD has returned to profit: it earned $0.06 per share over the past year, after losing money the year before.
AMAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2026 | $10.4B | +53% |
| Q3 2026 | $9.1B | +25% |
| Q2 2026 | $7.9B | +11% |
| Q1 2026 | $7B | -2.1% |
AMAT's revenue is growing: $10.4B last quarter, up 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +3.2 points |
| Q2 2026 | 32% | +1.3 points |
| Q1 2026 | 26% | -4.2 points |
| Q4 2025 | 25% | N/A |
| Q3 2025 | 31% | N/A |
| Q2 2025 | 31% | N/A |
| Q1 2025 | 30% | N/A |
AMAT has the edge over CRWD on profitability, with a higher operating margin.
CRWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +26% |
| Q2 2026 | $1.4B | +26% |
| Q1 2026 | $1.3B | +23% |
| Q4 2025 | $1.2B | +22% |
| Q3 2025 | $1.2B | +21% |
| Q2 2025 | $1.1B | +20% |
| Q1 2025 | $1.1B | +25% |
| Q4 2024 | $1B | +29% |
CRWD has the edge over AMAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.3% | +7.4 points |
| Q2 2026 | -2.2% | +9.1 points |
| Q1 2026 | 1.1% | +9.1 points |
| Q4 2025 | -5.6% | -0.1 points |
| Q3 2025 | -9.7% | -11 points |
| Q2 2025 | -11% | -12 points |
| Q1 2025 | -8.1% | -12 points |
| Q4 2024 | -5.5% | -5.9 points |
CRWD's operating margin was −2.3% last quarter, up 7.4 points from the same quarter a year ago.
AMAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +14% |
| Q2 2026 | $210M | -80% |
| Q1 2026 | $1B | +91% |
CRWD has the edge over AMAT in the latest year-over-year cash flow comparison.
CRWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $405.9M | +34% |
| Q2 2026 | $493.3M | +65% |
| Q1 2026 | $395.4M | +53% |
| Q4 2025 | $314.1M | +27% |
| Q3 2025 | $302.3M | +5.2% |
| Q2 2025 | $298.4M | -11% |
| Q1 2025 | $258.5M | -12% |
| Q4 2024 | $247.4M | -1.9% |
CRWD has the edge over AMAT in the latest year-over-year cash flow comparison.
AMAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1M shares |
| 1 year | -0.2% | -2M shares |
AMAT has the edge over CRWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $440M |
| Q2 2026 | $400M |
| Q1 2026 | $337M |
| Q4 2025 | $851M |
| Q3 2025 | $1.1B |
| Q2 2025 | $1.7B |
| Q1 2025 | $1.3B |
AMAT spent $2B buying back its own shares over the past year.
CRWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +12.9M shares |
| 1 year | +4.5% | +44.8M shares |
| 3 years | +7.8% | +75.9M shares |
| 5 years | +15% | +139M shares |
| Available history | +28% | +228M shares |
CRWD has 1B diluted shares, up 4.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $175.6M |
| Q1 2020 | — |
AMAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
AMAT's net debt is less than a year of its operating earnings (EBITDA).
CRWD Net Leverage
AMAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.8 | Neutral |
| Stochastic | 13.8 | Oversold |
AMAT's weekly RSI is 43 (neutral) and its Stochastic is 14 (oversold).
CRWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.1 | Neutral |
| Stochastic | 49.1 | Neutral |
CRWD's weekly RSI is 55 (neutral) and its Stochastic is 49 (neutral).
AMAT PE vs Technology Sector
| Metric | AMAT | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 28x | 8.4% above |
| PE % | 85 | 35 | 50 pts above |
AMAT has the edge over CRWD on valuation relative to its sector.
CRWD PE vs Technology Sector
| Metric | CRWD | Sector median | Relative |
|---|---|---|---|
| PE | 3,678x | 28x | 13,101% above |
| PE % | 91 | 35 | 56 pts above |
CRWD is trading at 3678x earnings, a 13101% premium to the Technology sector's median of 28x.
AMAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $427.8 | 11% below |
| 20 week MA | $477.9 | 20% below |
| 50 week MA | $418.0 | 8.9% below |
| 100 week MA | $298.5 | 28% above |
| 200 week MA | $232.1 | 64% above |
AMAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 64% above its 200-week average.
CRWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $247.4 | 7.1% below |
| 20 week MA | $221.9 | 3.6% above |
| 50 week MA | $163.0 | 41% above |
| 100 week MA | $136.0 | 69% above |
| 200 week MA | $97.5 | 136% above |
CRWD has the edge over AMAT on trend strength, trading above more of its moving averages.
AMAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.2 | $85.3 | +39% |
| 2021 | $85.3 | $155.5 | +82% |
| 2022 | $155.5 | $97.2 | -37% |
| 2023 | $97.2 | $162.1 | +67% |
| 2024 | $162.1 | $166.8 | +2.9% |
| 2025 | $166.8 | $261.9 | +57% |
| 2026 YTD | $261.9 | $381.0 | +45% |
AMAT has finished higher in five of the last six years, three of them by more than 50%. It's up 45% so far in 2026.
CRWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.2 | $55.3 | +352% |
| 2021 | $55.3 | $52.9 | -4.3% |
| 2022 | $52.9 | $25.5 | -52% |
| 2023 | $25.5 | $63.8 | +150% |
| 2024 | $63.8 | $88.8 | +39% |
| 2025 | $88.8 | $120.3 | +36% |
| 2026 YTD | $120.3 | $229.9 | +91% |
CRWD has the edge over AMAT on returns for 2026, with the stronger performance.